Cargando…

Effects of carvedilol therapy on cardiac autonomic control, QT dispersion, and ventricular arrhythmias in children with dilated cardiomyopathy

BACKGROUND: The purpose of this study was to examine the effects of carvedilol therapy on autonomic control of the heart and QT-interval dispersion (QTd) among children with idiopathic dilated cardiomyopathy (DCM) whose symptoms were not adequately controlled with standard congestive heart failure t...

Descripción completa

Detalles Bibliográficos
Autores principales: Oflaz, Mehmet Burhan, Balli, Sevket, Kibar, Ayse Esin, Ece, Ibrahim, Akdeniz, Celal, Tuzcu, Volkan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658865/
https://www.ncbi.nlm.nih.gov/pubmed/23686300
http://dx.doi.org/10.12659/MSM.883911
_version_ 1782270349669302272
author Oflaz, Mehmet Burhan
Balli, Sevket
Kibar, Ayse Esin
Ece, Ibrahim
Akdeniz, Celal
Tuzcu, Volkan
author_facet Oflaz, Mehmet Burhan
Balli, Sevket
Kibar, Ayse Esin
Ece, Ibrahim
Akdeniz, Celal
Tuzcu, Volkan
author_sort Oflaz, Mehmet Burhan
collection PubMed
description BACKGROUND: The purpose of this study was to examine the effects of carvedilol therapy on autonomic control of the heart and QT-interval dispersion (QTd) among children with idiopathic dilated cardiomyopathy (DCM) whose symptoms were not adequately controlled with standard congestive heart failure therapy. MATERIAL/METHODS: Patients with DCM who were treated with carvedilol were enrolled in the study. All patients had undergone carvedilol therapy in addition to standard therapy for at least 6 months. Clinical, echocardiographic, and electrocardiographic parameters, and 24-h Holter records of patients were retrospectively evaluated before and after carvedilol treatment. RESULTS: A total 34 patients (mean age: 7.4±4.3 years) with DCM were analyzed in the study. The median follow-up period was 9.5 months. After the 6 months of carvedilol therapy the clinical score significantly improved, left ventricular ejection fraction (LVEF) and fractional shortening (LVFS) significantly increased, and left ventricle end-diastolic dimensions and end-systolic dimensions significantly decreased. There were statistically significant increases in mean SDNN, SDANN, rMSSD, and pNN50 (p=0.002, p=0.001, p=0.008, and p=0.026, respectively). After the carvedilol therapy, SDNN was correlated with the clinical score, heart rate, LVEF, LVFS, and total premature ventricular contractions (PVCs). In addition, rMSSD and pNN50 were correlated with heart rate, LVEF and LVFS. A significant reduction was observed in QTc-minimum, QTc-maximum, and QTd values (434.9±40.7 vs. 416.1±36.5, 497.8±43.6 vs. 456.3±41.7, 58.6±17.1 vs. 49.3±15.6; p<0.001, p=0.001, and p=0.008, respectively). QTd was significantly related to PVCs (r=0.62, p=0.02). CONCLUSIONS: We conclude that the addition of carvedilol to standard therapy can improve clinical symptoms and heart rate variability, and reduce in arrhythmia markers in children with DCM.
format Online
Article
Text
id pubmed-3658865
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-36588652013-05-21 Effects of carvedilol therapy on cardiac autonomic control, QT dispersion, and ventricular arrhythmias in children with dilated cardiomyopathy Oflaz, Mehmet Burhan Balli, Sevket Kibar, Ayse Esin Ece, Ibrahim Akdeniz, Celal Tuzcu, Volkan Med Sci Monit Clinical Research BACKGROUND: The purpose of this study was to examine the effects of carvedilol therapy on autonomic control of the heart and QT-interval dispersion (QTd) among children with idiopathic dilated cardiomyopathy (DCM) whose symptoms were not adequately controlled with standard congestive heart failure therapy. MATERIAL/METHODS: Patients with DCM who were treated with carvedilol were enrolled in the study. All patients had undergone carvedilol therapy in addition to standard therapy for at least 6 months. Clinical, echocardiographic, and electrocardiographic parameters, and 24-h Holter records of patients were retrospectively evaluated before and after carvedilol treatment. RESULTS: A total 34 patients (mean age: 7.4±4.3 years) with DCM were analyzed in the study. The median follow-up period was 9.5 months. After the 6 months of carvedilol therapy the clinical score significantly improved, left ventricular ejection fraction (LVEF) and fractional shortening (LVFS) significantly increased, and left ventricle end-diastolic dimensions and end-systolic dimensions significantly decreased. There were statistically significant increases in mean SDNN, SDANN, rMSSD, and pNN50 (p=0.002, p=0.001, p=0.008, and p=0.026, respectively). After the carvedilol therapy, SDNN was correlated with the clinical score, heart rate, LVEF, LVFS, and total premature ventricular contractions (PVCs). In addition, rMSSD and pNN50 were correlated with heart rate, LVEF and LVFS. A significant reduction was observed in QTc-minimum, QTc-maximum, and QTd values (434.9±40.7 vs. 416.1±36.5, 497.8±43.6 vs. 456.3±41.7, 58.6±17.1 vs. 49.3±15.6; p<0.001, p=0.001, and p=0.008, respectively). QTd was significantly related to PVCs (r=0.62, p=0.02). CONCLUSIONS: We conclude that the addition of carvedilol to standard therapy can improve clinical symptoms and heart rate variability, and reduce in arrhythmia markers in children with DCM. International Scientific Literature, Inc. 2013-05-15 /pmc/articles/PMC3658865/ /pubmed/23686300 http://dx.doi.org/10.12659/MSM.883911 Text en © Med Sci Monit, 2013 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License
spellingShingle Clinical Research
Oflaz, Mehmet Burhan
Balli, Sevket
Kibar, Ayse Esin
Ece, Ibrahim
Akdeniz, Celal
Tuzcu, Volkan
Effects of carvedilol therapy on cardiac autonomic control, QT dispersion, and ventricular arrhythmias in children with dilated cardiomyopathy
title Effects of carvedilol therapy on cardiac autonomic control, QT dispersion, and ventricular arrhythmias in children with dilated cardiomyopathy
title_full Effects of carvedilol therapy on cardiac autonomic control, QT dispersion, and ventricular arrhythmias in children with dilated cardiomyopathy
title_fullStr Effects of carvedilol therapy on cardiac autonomic control, QT dispersion, and ventricular arrhythmias in children with dilated cardiomyopathy
title_full_unstemmed Effects of carvedilol therapy on cardiac autonomic control, QT dispersion, and ventricular arrhythmias in children with dilated cardiomyopathy
title_short Effects of carvedilol therapy on cardiac autonomic control, QT dispersion, and ventricular arrhythmias in children with dilated cardiomyopathy
title_sort effects of carvedilol therapy on cardiac autonomic control, qt dispersion, and ventricular arrhythmias in children with dilated cardiomyopathy
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658865/
https://www.ncbi.nlm.nih.gov/pubmed/23686300
http://dx.doi.org/10.12659/MSM.883911
work_keys_str_mv AT oflazmehmetburhan effectsofcarvediloltherapyoncardiacautonomiccontrolqtdispersionandventriculararrhythmiasinchildrenwithdilatedcardiomyopathy
AT ballisevket effectsofcarvediloltherapyoncardiacautonomiccontrolqtdispersionandventriculararrhythmiasinchildrenwithdilatedcardiomyopathy
AT kibarayseesin effectsofcarvediloltherapyoncardiacautonomiccontrolqtdispersionandventriculararrhythmiasinchildrenwithdilatedcardiomyopathy
AT eceibrahim effectsofcarvediloltherapyoncardiacautonomiccontrolqtdispersionandventriculararrhythmiasinchildrenwithdilatedcardiomyopathy
AT akdenizcelal effectsofcarvediloltherapyoncardiacautonomiccontrolqtdispersionandventriculararrhythmiasinchildrenwithdilatedcardiomyopathy
AT tuzcuvolkan effectsofcarvediloltherapyoncardiacautonomiccontrolqtdispersionandventriculararrhythmiasinchildrenwithdilatedcardiomyopathy